Synthesis and use of retinoid compounds having negative hormone and/or antagonist activities
申请人:Vision Pharmaceuticals L.P.
公开号:EP0931786A2
公开(公告)日:1999-07-28
The invention provides a compound of the formula
wherein X is S, O, NR' where R' is H or alkyl of 1 to 6 carbons, or
X is [C(R1)2]n where R1 is independently H or alkyl of 1 to 6 carbons, and n is an integer between 0 and 2;
R2 is hydrogen, lower alkyl of 1 to 6 carbons, F, Cl, Br, I, CF3, fluoro substituted alkyl of 1 to 6 carbons, OH, SH, alkoxy of 1 to 6 carbons, or alkylthio of 1 to 6 carbons;
R3 is hydrogen, lower alkyl of 1 to 6 carbons or F;
m is an integer having the value 0-3;
o is an integer having the value 0-3;
Y is a phenyl or naphthyl group, or heteroaryl selected from a group consisting of pyridyl, thienyl, furyl, pyridazinyl, pyrimidinyl, pyrazinyl, thiazolyl, oxazolyl, imidazolyl and pyrrazolyl, said phenyl and heteroaryl groups being optionally substituted with one or two R2 groups;
A is (CH2)q where q is 0-5, lower branched chain alkyl having 3-6 carbons, cycloalkyl having 3-6 carbons, alkenyl having 2-6 carbons and 1 or 2 double bonds, alkynyl having 2-6 carbons and 1 or 2 triple bonds;
B is hydrogen, COOH or a pharmaceutically acceptable salt thereof, COOR8, CONR9R10, -CH2OH, CH2OR11, CH2OCOR11, CHO, CH(OR12)2, CHOR13O, -COR7, CR7(OR12)2, CR7OR13O, or tri-lower alkylsilyl, where R7 is an alkyl, cycloalkyl or alkenyl group containing 1 to 5 carbons, R8 is an alkyl group of 1 to 10 carbons or trimethylsilylalkyl where the alkyl group has 1 to 10 carbons, or a cycloalkyl group of 5 to 10 carbons, or R8 is phenyl or lower alkylphenyl, R9 and R10 independently are hydrogen, an alkyl group of 1 to 10 carbons, or a cycloalkyl group of 5-10 carbons, or phenyl or lower alkylphenyl, R11 is lower alkyl, phenyl or lower alkylphenyl, R12 is lower alkyl, and R13 is divalent alkyl radical of 2-5 carbons, and
R14 is (R15)r-phenyl, (R15)r-naphthyl, or (R15)r-heteroaryl where the heteroaryl group has 1 to 3 heteroatoms selected from the group consisting of O, S and N, r is an integer having the values of 0-5, and
R15 is independently H, F, Cl, Br, I, NO2, N(R8)2, N(R8)COR8, NR8CON(R8)2, OH, OCOR8, OR8, CN, an alkyl group having 1 to 10 carbons, fluoro substituted alkyl group having 1 to 10 carbons, an alkenyl group having 1 to 10 carbons and 1 to 3 double bonds, alkynyl group having 1 to 10 carbons and 1 to 3 triple bonds, or a trialkylsilyl or trialkylsilyloxy group where the alkyl groups independently have 1 to 6 carbons;
R16 is H, lower alkyl of 1 to 6 carbons;
R17 is H, lower alkyl of 1 to 6 carbons, OH or OCOR11, and
p is zero or 1, with the proviso that when p is 1 then there is no R17 substituent group, and m is an integer between 0 and 2.
本发明提供了一种式如下的化合物
其中 X 是 S、O、NR',其中 R' 是 H 或 1 至 6 个碳原子的烷基,或
X 是[C(R1)2]n 其中 R1 独立地是 H 或 1 至 6 个碳原子的烷基,n 是 0 至 2 之间的整数;
R2 是氢、1 至 6 个碳原子的低级烷基、F、Cl、Br、I、CF3、1 至 6 个碳原子的氟取代烷基、OH、SH、1 至 6 个碳原子的烷氧基或 1 至 6 个碳原子的硫代烷基;
R3 是氢、1-6 个碳的低级烷基或 F;
m 是数值为 0-3 的整数;
o 是数值为 0-3 的整数;
Y 是苯基或萘基,或选自由吡啶基、噻吩基、呋喃基、哒嗪基、嘧啶基、吡嗪基、噻唑基、噁唑基、咪唑基和吡唑基组成的组的杂芳基,所述苯基和杂芳基可任选被一个或两个 R2 基团取代;
A 是 (CH2)q,其中 q 是 0-5、具有 3-6 个碳原子的低支链烷基、具有 3-6 个碳原子的环烷基、具有 2-6 个碳原子和 1 或 2 个双键的烯基、具有 2-6 个碳原子和 1 或 2 个三键的炔基;
B 是氢、COOH 或其药学上可接受的盐、COOR8、CONR9R10、-CH2OH、CH2OR11、CH2OCOR11、CHO、CH(OR12)2、CHOR13O、-COR7、CR7(OR12)2、CR7OR13O 或三低级烷基硅烷基、其中 R7 是含 1 至 5 个碳原子的烷基、环烷基或烯基,R8 是含 1 至 10 个碳原子的烷基或三甲基硅烷基(其中烷基含 1 至 10 个碳原子)、R9 和 R10 分别是氢、含 1 至 10 个碳原子的烷基、含 5 至 10 个碳原子的环烷基、苯基或低级烷基苯基,R11 是低级烷基、苯基或低级烷基苯基,R12 是低级烷基,R13 是含 2 至 5 个碳原子的二价烷基,以及
R14 是 (R15)r-苯基、(R15)r-萘基或 (R15)r-杂芳基,其中杂芳基具有 1 至 3 个选自 O、S 和 N 所组成的组的杂原子,r 是具有 0-5 值的整数,以及
R15 独立地是 H、F、Cl、Br、I、NO2、N(R8)2、N(R8)COR8、NR8CON(R8)2、OH、OCOR8、OR8、CN、具有 1 至 10 个碳原子的烷基、具有 1 至 10 个碳原子的氟取代烷基、具有 1 至 10 个碳原子和 1 至 3 个双键的烯基、具有 1 至 10 个碳原子和 1 至 3 个三键的炔基、或三烷基硅氧基或三烷基硅氧基(其中烷基独立具有 1 至 6 个碳原子);
R16 是 H、1 至 6 个碳原子的低级烷基;
R17 是 H、1 至 6 个碳原子的低级烷基、OH 或 OCOR11,以及
p 为 0 或 1,但当 p 为 1 时,不含 R17 取代基,且 m 为 0 至 2 之间的整数。